Breast cancer
Breast cancer is one of the most common malignant tumors in women, with an incidence rate of 7-10% of all malignant tumors in the body, second only to uterine cancer in women, and has become a major cause of threat to women's health. Its onset is often related to genetics, and the incidence rate is higher in women between the ages of 40 and 60, before and after menopause. It is one of the most common malignant tumors that usually occurs in breast glandular epithelial tissue, seriously affecting women's physical and mental health and even endangering their lives. Breast cancer in men is rare, with only about 1-2% of breast patients being male.
-
Site of disease:
breast -
Infectious :
Not contagious -
Frequent population:
Women aged 45-55, late menopause, over... -
Related symptoms:
Breast lumps Distant metastasis of breast cancer A palpable lump deep in the areola Swelling of axillary lymph nodes A peanut-sized lump on the lateral edge of the pectoralis major -
Concurrent disease:
Related Drugs
Epirubicin Hydrochloride Injection
Indication: Used to treat leukemia, malignant lymphoma, multiple myeloma, breast cancer, lung cancer, soft tissue sarcoma, gastric cancer, colorectal cancer, ovarian cancer, etc.
Epirubicin Hydrochloride Injection
Indication: Used to treat leukemia, malignant lymphoma, multiple myeloma, breast cancer, lung cancer, soft tissue sarcoma, gastric cancer, colorectal cancer, ovarian cancer, etc.
Epirubicin Hydrochloride Injection
Indication: Used to treat leukemia, malignant lymphoma, multiple myeloma, breast cancer, lung cancer, soft tissue sarcoma, gastric cancer, colorectal cancer, ovarian cancer, etc.
Epirubicin Hydrochloride Injection
Indication: Used to treat leukemia, malignant lymphoma, multiple myeloma, breast cancer, lung cancer, soft tissue sarcoma, gastric cancer, colorectal cancer, ovarian cancer, etc.
Ankangxin Capsules
Manufacturer:
Anhui Gaoshan Pharmaceutical Co., Ltd.
Lobaplatin
Indication: This product is mainly used to treat breast cancer, small cell lung cancer and chronic myeloid leukemia.
Manufacturer:
Hainan Changan International Pharmaceutical Co., Ltd.
Lobaplatin for injection
Indication: Treatment of inoperable metastatic breast cancer; treatment of inoperable transformed small cell lung cancer; treatment of chronic myeloid leukemia
Manufacturer:
Hainan Changan International Pharmaceutical Co., Ltd.
Lobaplatin for injection
Indication: Treatment of inoperable metastatic breast cancer; treatment of inoperable transformed small cell lung cancer; treatment of chronic myeloid leukemia
Manufacturer:
Hainan Changan International Pharmaceutical Co., Ltd.
Uropolyacitide injection
Indication: Combined with chemotherapy, it can be used for adjuvant treatment of advanced breast cancer and non-small cell lung cancer.
Vinorelbine tartrate injection
Indication: It is clinically used for non-small cell lung cancer, metastatic breast cancer, advanced ovarian cancer, malignant lymphadenopathy, etc.
Manufacturer:
Nanjing Cuccess Pharmaceutical Co., Ltd.
Related Ingredients
-
Epirubicin list
56420-45-2 -
Epirubicin hydrochloride list
56390-09-1 -
Psoralen list
66-97-7 -
2-(Aminomethyl)cyclobutyl]methanamine 2-hydroxypropanoic acid platinum salt list
131374-93-1 -
Hippuric acid list
495-69-2